Cassava Sciences, a US biotech developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, was ...

The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for belantamab ...

Danish biotech Adcendo today announced the successful closing of an oversubscribed $135 million Series B financing round. The ...

New research presented at the RSNA meeting suggests that levothyroxine, a common treatment for hypothyroidism, may contribute ...

US biopharma Biohaven has provided an update regarding the taldefgrobep alfa development programs in spinal muscular atrophy ...

The US Food and Drug Administration (FDA) on Friday approved Attruby (acoramidis), an orally-administered near-complete (≥90% ...

Positive top-line results from the Phase III ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary ...

UK pharma major AstraZeneca today released positive high-level results from the CAPItello-281 Phase III trial showing that ...

Lexicon Pharmaceuticals is shifting focus to its late-stage pipeline following the FDA's rejection of Zynquista for type 1 ...

Specialist preclinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has ...

In what could be construed to be India's quest for pharmaceutical supremacy, a clarion call has been made for the country to ...

A patient in Neurogene’s ongoing Phase I/II trial for Rett syndrome—who was dosed on November 5 with 3E15 vg of NGN-401—has ...